Effectiveness of 2 + 1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies
Highlights • Meta-analysis of IPD reduction in children 80% and optimal study design.
Gespeichert in:
| Veröffentlicht in: | Vaccine 2013-12, Vol.31 (50), p.5948-5952 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5952 |
|---|---|
| container_issue | 50 |
| container_start_page | 5948 |
| container_title | Vaccine |
| container_volume | 31 |
| creator | Schönberger, Katharina Kirchgässner, Katja Riedel, Christina von Kries, Rüdiger |
| description | Highlights • Meta-analysis of IPD reduction in children 80% and optimal study design. |
| doi_str_mv | 10.1016/j.vaccine.2013.10.042 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516753057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X13014187</els_id><sourcerecordid>3401045481</sourcerecordid><originalsourceid>FETCH-LOGICAL-c568t-8a8d44efcce9566aaf88f8662158bb79c6d91d9963de8a60e862e8d0897bf3343</originalsourceid><addsrcrecordid>eNqNkl9rFDEUxQdR7Lb6EdSAFASZNckkmaQPSlnqHygo1IpvIZvc2KyzmTWZWdhvb8ZdLfTFPl24_O65l3tOVT0jeE4wEW9W862xNkSYU0ya0ptjRh9UMyLbpqacyIfVDFPBakbw96PqOOcVxpg3RD2ujigjjDGhZlW88B7sELYQIWfUe0TRa0TQl8W3Fu03mCH0EWV7A27sIKMQkb0JnUsQ0RgdpDKyA5PyGTpHaxhMbaLpdjn8kQvrjbEDysPoAuQn1SNvugxPD_Wkun5_8XXxsb78_OHT4vyytlzIoZZGOsbAWwuKC2GMl9JLISjhcrlslRVOEaeUaBxIIzBIQUE6LFW79E3DmpPq1V53k_pfI-RBr0O20HUmQj9mTTgRLW8wb--Blq9RqcQ9UMaVahvBSUFf3kFX_ZjKXyZBTqXkBONC8T1lU59zAq83KaxN2mmC9WSzXumDzXqyeWoXm8vc84P6uFyD-zf119cCnB4Ak63pfDLRhnzLSUxw205CL_acN702P1Jhrq_KJo4xaRUlshDv9gQUu7YBks42QLTgQirB0a4P_z327R0F24UYylk_YQf59i86U4311ZTaKbSkwYRNcf4N-cnjNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552885100</pqid></control><display><type>article</type><title>Effectiveness of 2 + 1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Schönberger, Katharina ; Kirchgässner, Katja ; Riedel, Christina ; von Kries, Rüdiger</creator><creatorcontrib>Schönberger, Katharina ; Kirchgässner, Katja ; Riedel, Christina ; von Kries, Rüdiger</creatorcontrib><description>Highlights • Meta-analysis of IPD reduction in children <2 year suggested high effectiveness of the 2 + 1 vaccine schedule. • Beyond reported vaccination rates we identified two further determinants for heterogeneity; matching of periods of vaccination rates and case ascertainment; time gap between onset of vaccination programme and case ascertainment. • IRR of 98% may be identified with vaccination rates >80% and optimal study design.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2013.10.042</identifier><identifier>PMID: 24144469</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>2 + 1 vaccination schedule ; Age ; Allergy and Immunology ; Applied microbiology ; Biological and medical sciences ; case-control studies ; Children ; Fundamental and applied biological sciences. Psychology ; Heptavalent Pneumococcal Conjugate Vaccine ; Heterogeneity ; Humans ; Immunization ; Immunization Schedule ; Incidence ; Incidence reduction ; Infant ; Literature reviews ; Meta-analysis ; Microbiology ; PCV-7 ; Pneumococcal Infections - epidemiology ; Pneumococcal Infections - prevention & control ; Pneumococcal Vaccines - administration & dosage ; Pneumococcal Vaccines - immunology ; Pneumonia ; serotypes ; Streptococcus pneumoniae ; Studies ; Treatment Outcome ; vaccination ; Vaccination - methods ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><ispartof>Vaccine, 2013-12, Vol.31 (50), p.5948-5952</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 5, 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c568t-8a8d44efcce9566aaf88f8662158bb79c6d91d9963de8a60e862e8d0897bf3343</citedby><cites>FETCH-LOGICAL-c568t-8a8d44efcce9566aaf88f8662158bb79c6d91d9963de8a60e862e8d0897bf3343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X13014187$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28010772$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24144469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schönberger, Katharina</creatorcontrib><creatorcontrib>Kirchgässner, Katja</creatorcontrib><creatorcontrib>Riedel, Christina</creatorcontrib><creatorcontrib>von Kries, Rüdiger</creatorcontrib><title>Effectiveness of 2 + 1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights • Meta-analysis of IPD reduction in children <2 year suggested high effectiveness of the 2 + 1 vaccine schedule. • Beyond reported vaccination rates we identified two further determinants for heterogeneity; matching of periods of vaccination rates and case ascertainment; time gap between onset of vaccination programme and case ascertainment. • IRR of 98% may be identified with vaccination rates >80% and optimal study design.</description><subject>2 + 1 vaccination schedule</subject><subject>Age</subject><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>case-control studies</subject><subject>Children</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heptavalent Pneumococcal Conjugate Vaccine</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Schedule</subject><subject>Incidence</subject><subject>Incidence reduction</subject><subject>Infant</subject><subject>Literature reviews</subject><subject>Meta-analysis</subject><subject>Microbiology</subject><subject>PCV-7</subject><subject>Pneumococcal Infections - epidemiology</subject><subject>Pneumococcal Infections - prevention & control</subject><subject>Pneumococcal Vaccines - administration & dosage</subject><subject>Pneumococcal Vaccines - immunology</subject><subject>Pneumonia</subject><subject>serotypes</subject><subject>Streptococcus pneumoniae</subject><subject>Studies</subject><subject>Treatment Outcome</subject><subject>vaccination</subject><subject>Vaccination - methods</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkl9rFDEUxQdR7Lb6EdSAFASZNckkmaQPSlnqHygo1IpvIZvc2KyzmTWZWdhvb8ZdLfTFPl24_O65l3tOVT0jeE4wEW9W862xNkSYU0ya0ptjRh9UMyLbpqacyIfVDFPBakbw96PqOOcVxpg3RD2ujigjjDGhZlW88B7sELYQIWfUe0TRa0TQl8W3Fu03mCH0EWV7A27sIKMQkb0JnUsQ0RgdpDKyA5PyGTpHaxhMbaLpdjn8kQvrjbEDysPoAuQn1SNvugxPD_Wkun5_8XXxsb78_OHT4vyytlzIoZZGOsbAWwuKC2GMl9JLISjhcrlslRVOEaeUaBxIIzBIQUE6LFW79E3DmpPq1V53k_pfI-RBr0O20HUmQj9mTTgRLW8wb--Blq9RqcQ9UMaVahvBSUFf3kFX_ZjKXyZBTqXkBONC8T1lU59zAq83KaxN2mmC9WSzXumDzXqyeWoXm8vc84P6uFyD-zf119cCnB4Ak63pfDLRhnzLSUxw205CL_acN702P1Jhrq_KJo4xaRUlshDv9gQUu7YBks42QLTgQirB0a4P_z327R0F24UYylk_YQf59i86U4311ZTaKbSkwYRNcf4N-cnjNw</recordid><startdate>20131205</startdate><enddate>20131205</enddate><creator>Schönberger, Katharina</creator><creator>Kirchgässner, Katja</creator><creator>Riedel, Christina</creator><creator>von Kries, Rüdiger</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20131205</creationdate><title>Effectiveness of 2 + 1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies</title><author>Schönberger, Katharina ; Kirchgässner, Katja ; Riedel, Christina ; von Kries, Rüdiger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c568t-8a8d44efcce9566aaf88f8662158bb79c6d91d9963de8a60e862e8d0897bf3343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>2 + 1 vaccination schedule</topic><topic>Age</topic><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>case-control studies</topic><topic>Children</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heptavalent Pneumococcal Conjugate Vaccine</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Schedule</topic><topic>Incidence</topic><topic>Incidence reduction</topic><topic>Infant</topic><topic>Literature reviews</topic><topic>Meta-analysis</topic><topic>Microbiology</topic><topic>PCV-7</topic><topic>Pneumococcal Infections - epidemiology</topic><topic>Pneumococcal Infections - prevention & control</topic><topic>Pneumococcal Vaccines - administration & dosage</topic><topic>Pneumococcal Vaccines - immunology</topic><topic>Pneumonia</topic><topic>serotypes</topic><topic>Streptococcus pneumoniae</topic><topic>Studies</topic><topic>Treatment Outcome</topic><topic>vaccination</topic><topic>Vaccination - methods</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schönberger, Katharina</creatorcontrib><creatorcontrib>Kirchgässner, Katja</creatorcontrib><creatorcontrib>Riedel, Christina</creatorcontrib><creatorcontrib>von Kries, Rüdiger</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schönberger, Katharina</au><au>Kirchgässner, Katja</au><au>Riedel, Christina</au><au>von Kries, Rüdiger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of 2 + 1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2013-12-05</date><risdate>2013</risdate><volume>31</volume><issue>50</issue><spage>5948</spage><epage>5952</epage><pages>5948-5952</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Highlights • Meta-analysis of IPD reduction in children <2 year suggested high effectiveness of the 2 + 1 vaccine schedule. • Beyond reported vaccination rates we identified two further determinants for heterogeneity; matching of periods of vaccination rates and case ascertainment; time gap between onset of vaccination programme and case ascertainment. • IRR of 98% may be identified with vaccination rates >80% and optimal study design.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>24144469</pmid><doi>10.1016/j.vaccine.2013.10.042</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2013-12, Vol.31 (50), p.5948-5952 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1516753057 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | 2 + 1 vaccination schedule Age Allergy and Immunology Applied microbiology Biological and medical sciences case-control studies Children Fundamental and applied biological sciences. Psychology Heptavalent Pneumococcal Conjugate Vaccine Heterogeneity Humans Immunization Immunization Schedule Incidence Incidence reduction Infant Literature reviews Meta-analysis Microbiology PCV-7 Pneumococcal Infections - epidemiology Pneumococcal Infections - prevention & control Pneumococcal Vaccines - administration & dosage Pneumococcal Vaccines - immunology Pneumonia serotypes Streptococcus pneumoniae Studies Treatment Outcome vaccination Vaccination - methods Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) |
| title | Effectiveness of 2 + 1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T02%3A42%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%202%20+%201%20PCV7%20vaccination%20schedules%20in%20children%20under%202%20years:%20A%20meta-analysis%20of%20impact%20studies&rft.jtitle=Vaccine&rft.au=Sch%C3%B6nberger,%20Katharina&rft.date=2013-12-05&rft.volume=31&rft.issue=50&rft.spage=5948&rft.epage=5952&rft.pages=5948-5952&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2013.10.042&rft_dat=%3Cproquest_cross%3E3401045481%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1552885100&rft_id=info:pmid/24144469&rft_els_id=S0264410X13014187&rfr_iscdi=true |